Clinic photos coming soon
About Hirslanden Private Hospital
Klinik Hirslanden, located in Zurich, Switzerland, stands as a pillar of medical excellence within the Hirslanden Private Hospital Group, the largest and most prestigious medical network in the country. Founded in 1932 by Heinrich and Marie Hatt-Haller, the clinic was born from a vision to provide private doctors with the necessary infrastructure for surgical procedures and patient care. The original design by architect Hermann Weideli was so forward-thinking that its core structure remains relevant today, having been modernized to meet the highest contemporary standards. In 1990, Klinik Hirslanden, along with four other clinics, formed the Hirslanden Private Hospital Group, marking the creation of Switzerland's first private hospital consortium. The group has experienced continuous growth, especially after its acquisition by the Mediclinic Group in 2007, a partnership that has solidified its position as a leader in the Swiss healthcare landscape. The clinic's mission is deeply rooted in a holistic approach to patient care, guided by Jean Watson's theory of human caring. This philosophy emphasizes a profound respect for the individual, with a commitment to providing considerate, case-by-case treatment. The staff at Klinik Hirslanden are dedicated to the well-being of their patients, striving for excellent care outcomes through professional and initiative-driven behavior. Continuous personal and professional development is a cornerstone of their practice, ensuring that the team remains at the forefront of medical advancements. The clinic actively encourages and supports healthcare science and nursing innovations, integrating the latest findings into daily practice to advance the nursing profession and enhance patient care.
Klinik Hirslanden offers a comprehensive range of medical specialties, with a particular focus on oncology and hematology. The Tumour Centre Hirslanden Zurich, a certified center of excellence, provides a multidisciplinary approach to cancer treatment. In collaboration with Aarau Cantonal Hospital, the clinic offers autologous blood stem cell transplantation, a highly effective therapy for malignant diseases of the blood and bone marrow. This procedure involves high-dose chemotherapy, followed by the reinfusion of the patient's own stem cells to restore the blood and immune systems. The clinic is also at the forefront of genomic medicine, with its own laboratory, Hirslanden Precise, dedicated to providing personalized and targeted treatments based on individual genetic makeup. The facilities at Klinik Hirslanden are state-of-the-art, with 14 operating theaters, 3 delivery rooms, and a comprehensive suite of diagnostic imaging technologies, including MRI, CT, and PET scans. The clinic's commitment to quality is reflected in its numerous accolades, including a high ranking in Newsweek's "World's Best Hospitals." The patient experience at Klinik Hirslanden is characterized by a high level of satisfaction, with a significant majority of patients recommending the clinic to others. The clinic's dedication to patient-centered care, combined with its advanced medical technology and team of highly skilled professionals, makes it a premier destination for healthcare in Switzerland and beyond.
94+
Years Experience
2.7/5
Patient Rating
34
Patient Reviews
Clinic Information
Address
Witellikerstrasse 40, 8032 Zürich, Switzerland
Phone
+41 44 387 21 11Languages
German, English, French, Italian, Spanish, Dutch, Czech
Accreditations
JACIE
Treatments Offered
Medical Team
Dr. med. Sarah Abbeel
Specialist in Radio-oncology / radiotherapy
Dr. med. Bertrand Actor
Specialist in Neurosurgery
Dr. med. Sophia Agorastos-Florou
Specialist in Gynaecology and Obstetrics
Dr. med. Reto Agosti
Specialist in Neurology
Dr. med. Esther Amann-Adam
Specialist in Gynaecology and Obstetrics
Prof. Dr. med. Beatrice Amann-Vesti
Specialist in Angiology, General Internal Medicine
dipl. Ärztin Bettina Margit Anders
Specialist in Neurology
Dr. med. Alexandra Annen
Specialist in Otorhinolaryngology
Frequently Asked Questions
It is a procedure where a patient's own blood stem cells are collected and stored, and then reinfused after high-dose chemotherapy to treat malignant diseases of the blood and bone marrow.
This is the period after high-dose chemotherapy and before the transplanted stem cells start producing new blood cells. During this time, there is an increased risk of infection.
Patients are typically hospitalized in single rooms for around 3 weeks and are not permitted to leave their rooms during the critical aplasia phase.
It is an approach that examines a person's individual genetic make-up to tailor medical treatment accordingly, with the aim of providing more individualized and targeted treatment.
It is Hirslanden's own center of expertise for genomic medicine, offering all steps of genetic testing, from counseling to analysis and reporting.
Trust Score
43Get a Free Quote
By submitting, you agree to our privacy policy.